Director Srinivas Tallapragada filed a Form 4 with the SEC on November 12, 2026, disclosing the grant of 645 Deferred Stock Units and 2,659 stock options in Broadridge Financial Solutions, Inc. on November 10, 2026.

Key Highlights

  • Director role: Srinivas Tallapragada is listed as a director of Broadridge Financial Solutions, Inc. (NYSE:BR).
  • DSU grant: 645 Deferred Stock Units were acquired on November 10, 2026, at a price of $0.0000, under Broadridge's 2018 Omnibus Award Plan.
  • Immediate vesting: The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service.
  • Stock options granted: 2,659 stock options (right to buy common stock) were granted on November 10, 2026, at an exercise price of $192.96, vesting immediately upon grant.
  • Option expiration: The stock options are exercisable beginning November 10, 2026, and expire on November 10, 2036.
  • Post-transaction ownership: Following the reported transactions, Tallapragada directly holds 645 shares of common stock and 2,659 derivative securities.

Details of Tallapragada's November 2026 Director Grants at Broadridge

According to the filing, Srinivas Tallapragada, identified as a director of Broadridge Financial Solutions, Inc. (NYSE:BR), received two separate equity awards on November 10, 2026. The first was an acquisition of 645 shares of common stock in the form of Deferred Stock Units, coded as transaction type "A" (acquired), at a reported price of $0.0000. The filing states these units were granted under Broadridge's 2018 Omnibus Award Plan and "vest in full upon grant," with settlement in shares of Broadridge common stock occurring "upon the director's separation from service with Broadridge."

The second transaction involved the grant of 2,659 stock options carrying the right to buy Broadridge common stock at an exercise price of $192.96 per share. The filing states that these stock options also "vest immediately upon grant," with an exercisable date of November 10, 2026, and an expiration date of November 10, 2036. Both transactions are reported as directly owned. Following the reported transactions, Tallapragada's beneficial ownership stands at 645 shares of common stock directly and 2,659 stock options directly, as stated in the filing.

The Form 4 was signed by Maria Allen under a power of attorney and filed on November 12, 2026. The filing does not indicate that either transaction was made pursuant to a Rule 10b5-1(c) plan.

What Was Disclosed

The filing disclosed two equity grants to director Srinivas Tallapragada on November 10, 2026: 645 immediately vesting Deferred Stock Units at $0.0000 and 2,659 immediately vesting stock options at an exercise price of $192.96, expiring November 10, 2036.